CH19 - Regulating the Flow of Genetic Information

Flow of Gene-Expression Regulation – Big Picture

  • All instructions for life are encoded in the genome, but only a subset is expressed at any moment.
    • Selective expression conserves energy and lowers cancer risk (mis-expression can drive tumorigenesis).
  • Check-points where expression can be modulated
    • DNA access / chromatin state (not covered deeply here)
    • Transcription initiation\textbf{Transcription initiation} – ON/OFF decision for RNA polymerase (RNAP) at the promoter.
    • Post-transcriptional RNA processing – e.g. intron removal, 5′-capping, 3′ poly-A, RNA editing.
    • mRNA stability – decay vs. stabilization → copies available for translation.
    • Translation – initiation efficiency, ribosome access.
    • Post-translational protein modification (phosphorylation, methylation, etc.).
    • Protein transport/localization – cytoplasm ↔ nucleus, membranes, periplasm (in Gram-negative bacteria).
    • Protein degradation – half-life control via proteasome (eukaryotes) or bacterial proteases.

Transcription Initiation: Core Concepts

  • RNAP must bind promoter, change from closed complex (dsDNA) → open complex (melted bubble) to start RNA synthesis.
  • Bacterial promoter consensus sites: −10-10 (TATAAT) & −35-35 (TTGACA) recognized by σ-factor.
Constitutive vs. Regulated Genes
  • Constitutive (“house-keeping”) – expressed constantly at the same level; e.g. cell-wall enzymes. (Illustrated as always ≈3 mRNA copies.)
  • Regulated genes – expression changes in response to signals (nutrients, stress, etc.).
    • Control proteins = transcription factors (TFs) / regulators.
Activators & Repressors (Local Control)
  • Activator binding → stabilizes RNAP → ON (positive regulation). Site often just called “activator site.”
  • Repressor binding → blocks RNAP → OFF (negative regulation). Binding sequence frequently called operator.
Long-Range Control via DNA Looping
  • Regulators can bind distal sites and contact RNAP by looping.
    • Activator-mediated looping: distant site ↔ promoter → ON.
    • Repressor-mediated looping between two operators → loop occludes promoter → OFF.
  • Helper proteins that bend DNA = architectural regulators; bridge proteins = co-activators / co-repressors.
Insulators (Eukaryotes)
  • DNA elements + insulator proteins that prevent cross-talk between adjacent genes (block an enhancer for gene A from activating gene B).
Signal Integration Example – lac Operon (E. coli)
  • Three structural genes (lacZYA) needed for lactose import & catabolism.
  • Cell must evaluate two signals:
    1. Lactose present/absent → binds LacI repressor.
    2. Glucose present/absent → sets cAMP level → cAMP·CRP activator status.
  • Logic table (simplified):
    • Glucose present (preferred C-source) ⇒ operon OFF, regardless of lactose.
    • Glucose absent & lactose present ⇒ high cAMP, CRP binds activator site; lactose inactivates LacI → RNAP stabilized → operon strongly ON.
    • Lactose absent ⇒ LacI binds operator → OFF.
Effector Molecules & Regulatory Logic
  • Small ligands (effectors) bind TFs, altering DNA affinity.
  • Four canonical classes (combine Positive/Negative with Inducible/Repressible):
    • Negative–Inducible: effector (inducer) removes repressor → ON (e.g. lactose/LacI).
    • Negative–Repressible: effector (co-repressor) enables repressor DNA binding → OFF (e.g. tryptophan/TrpR).
    • Positive–Inducible: effector enables activator binding → ON (e.g. cAMP/CRP).
    • Positive–Repressible: effector causes activator release → OFF.
  • Mnemonic: “Inducer present ⇒ expression ON; Co-repressor present ⇒ expression OFF.”
Operons & Combinatorial Control
  • Operon / polycistronic RNA – single promoter/terminator controlling multiple ORFs (e.g. lacZYA, trpEDCBA).
  • Eukaryotes: “combinatorial control” – limited set of TFs used in distinct combinations for many genes (saves energy). Example scheme:
    • Gene X: TF A + B + C + D + E
    • Gene Y: TF B + C + E
    • Gene Z: TF A + B + D + F + G

Structural Basis of Transcriptional Regulation

Why the Major Groove?
  • Major groove presents more H-bond donors/acceptors & methyl groups → richer “chemical barcode” for base identification versus minor groove.
Regulatory Sites Often Inverted Repeats
  • Homodimeric TFs bind palindromic DNA; each monomer contacts one half-site.
Canonical DNA-Binding Motifs
MotifSize / FeaturesTypical OrganismsDNA Contact
Helix–Turn–Helix (HTH)≈20 aa; 2 α-helices joined by short turnFrequent in bacteria, some eukaryotesRecognition helix inserts into major groove
Homeodomain≈60 aa; 3 helices; N-terminal arm contacts minor grooveMulticellular eukaryotesHelix 3 = recognition helix
Leucine Zipper (bZIP)Amphipathic α-helices with Leu every 7 aa ⇒ dimeric “zipper”Animals, yeastBasic region (Lys/Arg) binds major groove; zipper holds dimer
Helix–Loop–Helix (bHLH)50 aa; two helices separated by flexible loop, often amphipathicMany eukaryotesBasic region binds DNA; HLH mediates dimerization
Zinc Finger≈30 aa per finger; Cys₂His₂ (or Cys₄) coordinate Zn²⁺; α-helix + β-strandEukaryotes (abundant)Each finger contacts one major-groove interval; do not require dimerization
Modular Domain Architecture
  • TFs often = DNA-binding domain + separate regulatory (activation/repression) domain.
  • Classic experiment (Kadoch/Kadner et al.): fused LexA DNA-binding domain to Gal4 activation domain; reporter with LexA site upstream of GAL promoter → β-galactosidase expressed only when both modules present ⇨ domains are functionally separable.
  • Concept borrowed by yeast two-hybrid screens.

Post-Transcriptional Regulation

Attenuation (Bacteria)
  • Acts like a conditional intrinsic terminator.
  • Example: trp operon
    • Leader RNA can fold into 3:4 terminator stem-loop followed by U-tract → RNAP falls off.
    • High charged tRNA
      t_Trp allows ribosome to quickly clear region 1➜2, promoting 3:4 pairing (terminator) ⇒ transcription stops when Trp abundant.
    • Low Trp ➜ ribosome stalls, 2:3 anti-terminator forms ⇒ transcription continues through trpEDCBA genes.
Transcription Elongation Control (Eukaryotes)
  • RNAP II associates with multiple elongation factors; phosphorylation pattern of CTD and factor availability modulate pause/release.
Alternative Splicing
  • Different splice-site use alters exon composition.
    • Splicing activators/repressors (SR proteins, hnRNPs) bind enhancer/silencer elements to select sites.
    • Example diagram: full inclusion of exons 1-4 vs. skipping exon 2 when inner splice sites blocked.
mRNA Stability & Localization
  • 5′ cap + 3′ poly-A protect transcript; also bind export & translation factors.
  • Small RNAs (sRNAs in bacteria; miRNA/siRNA in eukaryotes):
    • Base-pair to mRNA → inhibit ribosome binding (often Shine-Dalgarno), stimulate or prevent degradation.
    • Dicer processes dsRNA → 21-25 nt miRNA; loaded into RISC; outcomes:
    • Perfect pairing → mRNA cleavage
    • Imperfect pairing → translational repression / deadenylation.
Post-Translational Modifications (PTMs)
  • Phosphorylation, acetylation, methylation, ubiquitination, glycosylation, etc.
  • Example – JAK/STAT pathway (cytokine signaling):
    1. Cytokine binds receptor → dimerizes JAK kinases.
    2. JAKs auto-phosphorylate then phosphorylate STAT.
    3. Phospho-STAT dimerizes, exposes NLS → imported to nucleus.
    4. STAT acts as TF → target gene ON.
  • Histone PTMs alter chromatin structure, impacting large swaths of transcription.
Protein Degradation
  • Eukaryotes: proteins tagged with poly-ubiquitin (Ub) via E1/E2/E3 enzymes.
    • Ub chain recognized by 26 kDa26\,\text{kDa} proteasome core → ATP-dependent unfolding and proteolysis.
  • Bacteria: no ubiquitin; oxidized/misfolded proteins expose hydrophobic patches → recognized by bacterial proteasome-like complexes (e.g. ClpXP, Lon).

Ethical, Philosophical & Practical Notes

  • Precise regulation conserves limited cellular energy; mis-regulation can waste resources or induce disease.
  • Cancer prevention: avoiding inappropriate gene activation (e.g. proto-oncogenes) lowers mutational pressure.
  • Biotechnology: manipulating promoters, TF motifs, or Ub-tags enables synthetic-biology circuits, therapeutic protein control, or gene-silencing therapies (siRNA/miRNA, CRISPRi).